G&E Herbal Biotechnology Co., Ltd. Reports Earnings Results for the Third Quarter Ended September 30, 2019
November 06, 2019 at 11:50 am EST
Share
G&E Herbal Biotechnology Co., Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was TWD 5.114 million compared to TWD 425,000 a year ago. Operating loss was TWD 6.169 million compared to TWD 7.743 million a year ago. Net loss was TWD 5.957 million compared to TWD 4.696 million a year ago. Basic loss per share was TWD 0.11 compared to TWD 0.09 a year ago. For the nine months, sales was TWD 12.652 million compared to TWD 541,000 a year ago. Operating loss was TWD 21.082 million compared to TWD 29.105 million a year ago. Net loss was TWD 20.180 million compared to TWD 16.037 million a year ago. Basic loss per share was TWD 0.36 compared to TWD 0.29 a year ago.
G&E Herbal Biotechnology Co., Ltd is a Taiwan-based company principally engaged in the research and development, manufacture and distribution of health care food products, functional skin care products and pharmaceutical products. Its health care food products include accessory food products and capsules for cancer and urogenital disorder. The Company also provides botanical medicines for cancers and liver diseases. The Company distributes its products within domestic market and to overseas markets.
G&E HERBAL BIOTECHNOLOGY CO., LTD. 
